{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T01:12:38Z","timestamp":1773277958962,"version":"3.50.1"},"reference-count":16,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2003,1,1]],"date-time":"2003-01-01T00:00:00Z","timestamp":1041379200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The American Journal of the Medical Sciences"],"published-print":{"date-parts":[[2003,1]]},"DOI":"10.1097\/00000441-200301000-00011","type":"journal-article","created":{"date-parts":[[2003,11,10]],"date-time":"2003-11-10T11:28:16Z","timestamp":1068463696000},"page":"48-50","source":"Crossref","is-referenced-by-count":24,"title":["Thyrotropin-Secreting Pituitary Adenoma Presenting as Hypokalemic Periodic Paralysis"],"prefix":"10.1016","volume":"325","author":[{"given":"Feng-Sheng","family":"Hsu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Han-Hsiang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi-Chou","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weng-Sheng","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tom","family":"Chau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shih-Hua","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1097\/00000441-200301000-00011_bb0010","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1093\/qjmed\/94.3.133","article-title":"Hypokalaemia and paralysis","volume":"94","author":"Lin","year":"2001","journal-title":"Q J Med"},{"key":"10.1097\/00000441-200301000-00011_bb0015","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1097\/00005792-199205000-00001","article-title":"Thyrotoxic periodic paralysis in the United States: report of 7 cases and review of the literature","volume":"71","author":"Ober","year":"1992","journal-title":"Medicine Baltimore"},{"key":"10.1097\/00000441-200301000-00011_bb0020","doi-asserted-by":"crossref","first-page":"399","DOI":"10.2169\/internalmedicine1962.29.399","article-title":"A case of thyrotropin (TSH)-secreting tumor complicated by periodic paralysis","volume":"29","author":"Kiso","year":"1990","journal-title":"Jpn J Med"},{"key":"10.1097\/00000441-200301000-00011_bb0025","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1007\/BF03350802","article-title":"A thyrotropin-secreting pituitary tumor as a cause of thyrotoxic periodic paralysis","volume":"21","author":"Alings","year":"1998","journal-title":"J Endocrinol Invest"},{"key":"10.1097\/00000441-200301000-00011_bb0030","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1053\/ajkd.2001.22090","article-title":"Propranolol rapidly terminates the hypokalemia, hypophosphatemia and paralysis in thyrotoxic periodic paralysis","volume":"37","author":"Lin","year":"2001","journal-title":"Am J Kidney Dis"},{"key":"10.1097\/00000441-200301000-00011_bb0035","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1001\/archinte.159.6.601","article-title":"Clinical and metabolic features of thyrotoxic periodic paralysis in 24 episodes","volume":"159","author":"Manoukain","year":"1999","journal-title":"Arch Intern Med"},{"key":"10.1097\/00000441-200301000-00011_bb0040","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/0022-510X(71)90005-0","article-title":"Studies in thyrotoxic periodic paralysis","volume":"13","author":"Norris","year":"1972","journal-title":"J Neurol Sci"},{"key":"10.1097\/00000441-200301000-00011_bb0045","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1212\/WNL.24.10.949","article-title":"Periodic paralysis caused by abuse of thyroid hormone","volume":"24","author":"Layzer","year":"1974","journal-title":"Neurology"},{"key":"10.1097\/00000441-200301000-00011_bb0050","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1081\/JDI-100001294","article-title":"Thyrotoxic periodic paralysis in a patient abusing thyroxine for weight reduction","volume":"23","author":"Chen","year":"2001","journal-title":"Ren Fail"},{"key":"10.1097\/00000441-200301000-00011_bb0055","doi-asserted-by":"crossref","first-page":"2597","DOI":"10.1001\/archinte.1989.00390110139031","article-title":"Thyrotoxic periodic paralysis. Report of 10 cases and review of electromyographic findings","volume":"149","author":"Kelley","year":"1989","journal-title":"Arch Intern Med"},{"key":"10.1097\/00000441-200301000-00011_bb0060","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1001\/archinte.1981.00340120063014","article-title":"Lymphocytic thyroiditis with spontaneously resolving hyperthyroidism and subacute thyroiditis. Long-term follow-up","volume":"141","author":"Nikolai","year":"1981","journal-title":"Arch Intern Med"},{"key":"10.1097\/00000441-200301000-00011_bb0065","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/ng0394-267","article-title":"Mapping of the hypokalemic periodic paralysis (HypoPP) locus to chromosome 1q31\u201332 in three European families","volume":"6","author":"Fontaine","year":"1994","journal-title":"Nat Genet"},{"key":"10.1097\/00000441-200301000-00011_bb0070","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1093\/brain\/124.6.1091","article-title":"Hypokalemic periodic paralysis type 2 caused by mutations at codon 672 in the muscle sodium channel gene SCN4A","volume":"124","author":"Sternberg","year":"2001","journal-title":"Brain"},{"key":"10.1097\/00000441-200301000-00011_bb0075","first-page":"610","article-title":"Thyrotropin-secreting pituitary tumors","volume":"17","author":"Beck-Peccoz","year":"1996","journal-title":"Endocr Rev"},{"key":"10.1097\/00000441-200301000-00011_bb0080","doi-asserted-by":"crossref","first-page":"281","DOI":"10.7326\/0003-4819-96-3-281","article-title":"Size reduction of extrasellar pituitary tumors during bromocriptine treatment","volume":"96","author":"Wollesen","year":"1982","journal-title":"Ann Intern Med"},{"key":"10.1097\/00000441-200301000-00011_bb0085","first-page":"540","article-title":"Somatostatin receptors on thyrotropin-secreting pituitary adenoma: comparison with the inhibitory effect of octreotide up in vivo and in vitro hormonal secretions","volume":"75","author":"Bertherat","year":"1992","journal-title":"J Clin Endocrinol Metab"}],"container-title":["The American Journal of the Medical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002962915343445?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002962915343445?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,17]],"date-time":"2019-02-17T06:27:59Z","timestamp":1550384879000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002962915343445"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,1]]},"references-count":16,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2003,1]]}},"alternative-id":["S0002962915343445"],"URL":"https:\/\/doi.org\/10.1097\/00000441-200301000-00011","relation":{},"ISSN":["0002-9629"],"issn-type":[{"value":"0002-9629","type":"print"}],"subject":[],"published":{"date-parts":[[2003,1]]}}}